Tabolacci, C.; Giordano, D.; Rossi, S.; Cordella, M.; D’Arcangelo, D.; Moschella, F.; D’Atri, S.; Biffoni, M.; Facchiano, A.; Facchiano, F.
Identification of Dihydrolipoamide Dehydrogenase as Potential Target of Vemurafenib-Resistant Melanoma Cells. Molecules 2022, 27, 7800.
https://doi.org/10.3390/molecules27227800
AMA Style
Tabolacci C, Giordano D, Rossi S, Cordella M, D’Arcangelo D, Moschella F, D’Atri S, Biffoni M, Facchiano A, Facchiano F.
Identification of Dihydrolipoamide Dehydrogenase as Potential Target of Vemurafenib-Resistant Melanoma Cells. Molecules. 2022; 27(22):7800.
https://doi.org/10.3390/molecules27227800
Chicago/Turabian Style
Tabolacci, Claudio, Deborah Giordano, Stefania Rossi, Martina Cordella, Daniela D’Arcangelo, Federica Moschella, Stefania D’Atri, Mauro Biffoni, Angelo Facchiano, and Francesco Facchiano.
2022. "Identification of Dihydrolipoamide Dehydrogenase as Potential Target of Vemurafenib-Resistant Melanoma Cells" Molecules 27, no. 22: 7800.
https://doi.org/10.3390/molecules27227800
APA Style
Tabolacci, C., Giordano, D., Rossi, S., Cordella, M., D’Arcangelo, D., Moschella, F., D’Atri, S., Biffoni, M., Facchiano, A., & Facchiano, F.
(2022). Identification of Dihydrolipoamide Dehydrogenase as Potential Target of Vemurafenib-Resistant Melanoma Cells. Molecules, 27(22), 7800.
https://doi.org/10.3390/molecules27227800